Research and Markets: Therapeutic Drug Monitoring - Technologies, Markets, and Companies - 2013

TDM market is analyzed from 2011 to 2021 according to technologies as well as geographical distribution. The report also contains profiles of 27 companies involved in developing tests and equipment for drug monitoring along with their collaborations.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Therapeutic Drug Monitoring - Technologies, Markets, and Companies - 2013

Dublin, Ireland (PRWEB) February 25, 2013

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Therapeutic Drug Monitoring - Technologies, Markets, and Companies" to their offering.

This report deals with therapeutic drug monitoring, a multi-disciplinary clinical specialty, aimed at improving patient care by monitoring drug levels in the blood to individually adjust the dose of drugs for improving outcome. TDM is viewed as a component of personalized medicine that interacts with several other disciplines including pharmacokinetics and pharmacogenetics. One chapter is devoted to monitoring of drugs of abuse (DoA). Various technologies used for well-known DoA are described. A section on drug abuse describes methods of detection of performance-enhancing drugs. Therapeutic Drug Monitoring market is analyzed from 2011 to 2021 according to technologies as well as geographical distribution. Global market for DoA testing was also analyzed from 2011 to 2021 and divided according to the area of application. Unmet needs and strategies for development of markets for TDM are discussed. The report contains profiles of 27 companies involved in developing tests and equipment for drug monitoring along with their collaborations. The text is supplemented with 17 tables, 6 figures and 150 selected references from literature.

Benefits of this report

  • Up-to-date one-stop information on therapeutic drug monitoring
  • Description of 27 companies involved with their collaborations in this area
  • Market analysis 2012-2022
  • Market values in major regions
  • Strategies for developing markets for therapeutic drug monitoring
  • A selected bibliography of 150 publications
  • Text is supplemented by 17 tables and 6 figures

Who should read this report?

  • Biotechnology companies developing assays and equipment for drug monitoring
  • Reference laboratories providing drug monitoring services
  • Pharmaceutical companies interested in companion tests for monitoring their drugs
  • Clinical pharmacologists interested in integrating therapeutic drug monitoring with pharmacogenetics for development of personalized medicine

Key Topics Covered:

Executive Summary

1. Introduction

2. Technologies for TDM

3. Drug Monitoring Instruments

4. Applications of TDM

5. Drugs Requiring Monitoring

6. Monitoring of Biological Therapies

7. Monitoring of Drug Abuse

8. Markets for TDM

9. Companies

10. References

For more information visit http://www.researchandmarkets.com/research/8znmg3/therapeutic_drug

Source: Jain PharmaBiotech

Research and Markets
Laura Wood, Senior Manager.
press(at)researchandmarkets(dot)com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


Contact

Follow us on: Contact's LinkedIn